Learn how to invest in the growing industry of genomics and get a list of the field's most promising companies.

Genomics encompasses the study of a complete set of genes, their work process, and their way of interacting with each other and the environment. While it incorporates elements of genetics, the primary ...

Biotech company 10x Genomics (NASDAQ:TXG) reported in Q1 CY2026, but sales fell by 2.6% year on year to $150.8 million. The ...

An updated edition of the March 28, 2025, article. The rapid evolution of genomics, the study of genes and their functions, in recent times has paved the way for a revolutionary era in genetic ...

For the quarter ended March 2026, 10x Genomics (TXG) reported revenue of $150.84 million, down 2.6% over the same period last year. EPS came in at -$0.10, compared to -$0.36 in the year-ago quarter.

Gene sequencing technology company 10x Genomics (NASDAQ: TXG) hasn't been having it easy in the past few days on the stock market. A bearish analyst move dampened sentiment on the company, and ...

Genomics is on the brink of revolutionizing healthcare with breakthroughs that could redefine treatment and diagnosis. As this field rapidly evolves, investing in fundamentally sound genomics stocks ...

10x Genomics (TXG) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.29. This compares to a loss of $0.36 per share a year ago. These figures are ...

Genomics is the study of genes and how they operate. Numerous quickly expanding businesses are arising in the genomics industry as a result of technological advancements that significantly reduce the ...

In this article, we will discuss: 12 Best Genomics Stocks to Invest In. Companies that study DNA to improve people’s lives are known as genomics stocks. These businesses often fit into one of three ...